AXXAM

Event

Axxam at the Italian HCS User Group Meeting 2026

Photo of Fernanda Ricci

Fernanda Ricci

Head | Advanced Cellular Assays

What can we learn from cells when we look beyond a single measurement?

High-Content Screening (HCS) enables researchers to investigate complex cellular responses by combining automated microscopy, image analysis, and multiparametric data acquisition. From phenotypic profiling to the identification of subtle biological changes, this technology provides valuable insights into cellular behavior.

On November 27, Axxam will participate in the Italian HCS User Group Meeting 2026 in Trieste, joining researchers and technology experts to exchange experiences and explore developments in high-content imaging and cellular analysis.

Fernanda Ricci, Head of Advanced Cellular Assays at Axxam, will represent our team at the meeting.

Seeing More, Understanding More

Cells can reveal much more than a simple active or inactive response.

Through High-Content Imaging and phenotypic screening, Axxam investigates cellular morphology, protein localization, organelle function, and other disease-relevant features to generate detailed biological profiles.

By combining advanced cellular models with quantitative imaging and multiparametric analysis, we support applications ranging from target validation to compound characterization and early drug discovery.

These approaches help uncover biological effects that may remain undetected with conventional single-readout assays.

Meet us in Trieste

The Italian HCS User Group Meeting offers an opportunity to share practical experiences, discuss technical challenges, and discover new applications of high-content technologies.

Attending the meeting? Connect with Fernanda Ricci to exchange ideas on cellular imaging, phenotypic screening, and advanced assay development.

Scroll to Top